The goal of the Institute is to identify and support advancements in medication management to help improve the safety and cost of health care by encouraging transformational ways of thinking, new methods, processes, guidelines and best practices to create a foundation for measurable improvements” BD (2017).
BD report “BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its new BD Institute for Medication Management Excellence, developed to help advance the safe and efficient management of medication across the continuum of care.
As part of the company’s established Center for Safety and Clinical Excellence, the new BD Institute of Medication Management Excellence is uniquely designed to offer a collaborative environment for customers and industry thought leaders to engage in insightful research and best practices to directly impact patient safety. The goal of the Institute is to identify and support advancements in medication management to help improve the safety and cost of health care by encouraging transformational ways of thinking, new methods, processes, guidelines and best practices to create a foundation for measurable improvements.
ReTweet if useful… New BD institute for medication management excellence aims to improve patient safety https://ctt.ec/n16cd+ @ivteam #ivteam
The BD Institute of Medication Management Excellence will initially be focused on three initiatives dedicated to improving patient outcomes and delivering patient-centered care through simpler, safer and more cost-effective medication practices, processes and policies across the continuum of care. Key initiatives include:
- Opioid Control and Management: BD is collaborating with national health care organizations and health systems to address clinical and operational medication management and drug diversion issues in acute care settings to define and promote solutions that health care organizations can implement to address the rising opioid epidemic.
- End-to-end IV Safety: In collaboration with national experts and IV safety organizations, BD is working to improve comprehensive IV infusion safety through the entire process from initial compounding to administration at the patient’s bedside.
- Medication Availability: BD is working with medication management experts to ensure that the right medication is available when and where needed to improve patient outcomes and cost-efficiencies across the continuum of care. As showcased at the 2016 American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Las Vegas, BD demonstrated an enhanced technology platform designed to eliminate the communication gaps between disparate technologies and help optimize the entire medication management process. Through this comprehensive approach towards medication management, BD demonstrated new, integrated software capabilities, including: suggestive analytics around inventory management, software applications to drive workflow efficiencies and benchmarking capabilities.”
Full Press Release
Thank you to our partners for supporting IVTEAM
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes Through Collaboration